MedTrace Logo

D-Dimer Guided Oral Anticoagulant Treatment (OAT)

NCT00895505 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2009-05-08

No results posted yet for this study

Summary

This clinical trial will investigate the hypothesis that D-Dimer testing can be successfully used to tailor the duration of OAT in patients after an unprovoked episode of deep venous thrombosis (DVT) using a prospective, randomized, and controlled design.

Conditions

  • Deep Venous Thrombosis

Interventions

DRUG

Phenprocoumon

Phenprocoumon 3 mg, tablet, INR adjusted

DRUG

Warfarin-Natrium

Warfarin-Natrium 5 mg, tablet, INR adjusted

Sponsors & Collaborators

  • German Research Foundation

    collaborator OTHER

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University Hospital, Bonn

    lead OTHER

Principal Investigators

  • Bernd Poetzsch, Professor · Institut für Experimentelle Hämatologie und Transfusionsmedizin, Universitätsklinikum Bonn

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00895505 on ClinicalTrials.gov